FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37847211000001102: Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
477261000001112 Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
477271000001119 Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Is a Octreotide 30mg powder and solvent for suspension for injection vials true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Is a Olatuton true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has specific active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial Has AMP True Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start